Texas Medical Board opens applications for new physician license pathways under DOCTOR Act

Law creates provisional licenses for foreign-trained doctors and unmatched graduates to expand medical workforce

Translate to Spanish or other 102 languages!

The Texas Medical Board has begun accepting applications for two new physician license categories created by House Bill 2038, known as the DOCTOR Act, expanding pathways for internationally trained physicians and medical school graduates who did not secure residency positions. Image for illustration purposes
The Texas Medical Board has begun accepting applications for two new physician license categories created by House Bill 2038, known as the DOCTOR Act, expanding pathways for internationally trained physicians and medical school graduates who did not secure residency positions. Image for illustration purposes
- Advertisement -

Mega Doctor News

The Texas Medical Board has begun accepting applications for two new physician license categories created by House Bill 2038, known as the DOCTOR Act, expanding pathways for internationally trained physicians and medical school graduates who did not secure residency positions.

The law, which amended the Texas Occupations Code, directs the Texas Medical Board to issue new types of licenses to “certain foreign medical license holders and physician graduates,” establishing alternative routes to practice medicine in the state. These license categories are listed on the agency’s website as Foreign Physician Provisional Licenses and Physician Graduate Licenses.

- Advertisement -

HB 2038, enacted in 2025 and implemented through new board rules, was designed to address physician shortages and expand access to care by allowing qualified doctors to practice under defined conditions. The DOCTOR Act “provides new pathways to licensing foreign-trained physicians and medical school graduates who do not match into a resident training program,” according to rulemaking summaries and board announcements.

Under the provisional license pathway, internationally trained physicians must meet strict eligibility requirements, including holding a recognized medical degree, maintaining a license in good standing abroad, demonstrating English proficiency, and passing the Texas Medical Jurisprudence Exam. Applicants must also have an employment offer from a Texas health care provider and authorization to work in the United States. The provisional license allows eligible physicians to begin practicing under supervision and, after meeting additional requirements, to apply for a full Texas license. 

The new Physician Graduate License is intended for medical school graduates who completed their education but did not match into a residency program, a situation that can delay or prevent licensure. The DOCTOR Act specifically created licensing pathways to capture this group of trained physicians and expand the available workforce.

The Texas Medical Board has published application instructions, eligibility criteria, and fee requirements on its website and is advising prospective applicants to review all documentation carefully before submitting materials. The agency has rulemaking authority under the law to establish application procedures, eligibility standards, and licensing fees. 

- Advertisement -

State officials and medical organizations have described the new licenses as part of an effort to increase physician capacity, particularly in underserved areas, while maintaining regulatory oversight. The opening of applications marks the first operational step in implementing the DOCTOR Act’s licensing framework.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -